Novartis NOVN0.61%increase; green up pointing triangle said its Vanrafia drug slows the decline in kidney function for adults with the progressive autoimmune kidney disease, IgA nephropathy (IgAN).
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results